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Abstract—A new family of annulated inositols (inosito-inositols) has been conceptualized. Naphthalene has been elaborated into
novel cyclohexa-annulated neo- and chiro-inositols, with two additional hydroxyl functionalities, through a series of stereoselective
oxyfunctionalization protocols. The trans-ring fusion present in these new annulated inositols ensures conformational locking.
Recently, we have introduced polycylitols as new enti-
ties, which can be regarded as either fused (annulated)
or hybrid variants of biologically important monocycli-
tols like conduritols and carbasugars.1 For example,
octahydroxy decalin 1 can be considered as a hybrid of
two conduritol molecules 2, constituted through a com-
mon, shared ring junction.1c Similarly, 1 can also be
visualized as a hybrid of carbasugar 3 (see, bold portion
in 1). We have accomplished the synthesis of bicyclitols
1 and related compounds and found potent and selec-
tive -glucosidase inhibitory activity in some of
them.1c,d These observations spurred us to conceptual-
ize novel polycyclitols (decahydroxy-decalins) based on
inositols 4, structurally similar to 2 and 3 but with an
enhanced oxygenation level. Inositols 4 and their
derivatives have been implicated in many diverse and
important biological functions among which the ability
of inositol triphosphate [Ins(1,4,5)P3] to act as sec-
ondary messenger by binding to specific receptors on
the endoplasmic reticulum and stimulating the release
of calcium ions from the intracellular stores is most
significant.2 Recognising the importance of inositols 4,
we propose bicyclic inositols 5 (inosito-inositols) as new
structural motifs that might exhibit unusual biological
properties and metal binding characteristics. Our efforts
en route to 5 have resulted in the synthesis of some new
bicyclic inositols 6 with as many as eight hydroxyl
groups on the decalin framework. The two additional
hydroxyl groups in the annulated ring as in 6 can act as
promoters of additional binding interactions along with
the inositol core. In addition, the trans-ring fusion in 6
ensures conformational locking and these annulated
inositols exist in ‘un-natural’ conformations (vide infra)
as demonstrated by us recently for related systems.3,4
Our synthetic approach towards 6 commenced from
tetrahydronaphthalene 7, readily available from naph-
thalene via metal-ammonia reduction. Controlled
OsO4-mediated dihydroxylation of 7, furnished the
regioisomeric cis-diols 8 and 9 (1:8) in which the
required isomer 9 predominated (Scheme 1). Epoxida-
tion of 9 (R=H) with mCPBA furnished a mixture of
syn-10 and anti-epoxide 11 (2:1) (Scheme 2).5,6 Interest-
ingly, protecting groups on the diol moiety of 9 could
Scheme 1. Reagents and conditions : (a) OsO4 (1 mol%),
NMMO, acetone:water (4:1), 10°C, 60%.* Corresponding author. E-mail: gm@orgchem.iisc.ernet.in
Scheme 2.
treatment with base underwent regio- and stereoselec-
tive transetherification as well as dehydrobromination
in a single pot operation to furnish the tricyclic com-
pound 14 with an embedded oxabicyclo[2.2.1]heptene
moiety (Scheme 3).6 The presence of the bridged
oxanorbornyl moiety ensured that the catalytic OsO4
dihydroxylation of 14 was stereoselective from the exo-
face and acetylation furnished the tetra-acetate 15. The
ether linkage in the oxabicyclo[2.2.1]heptene moiety
now needed to be cleaved and after some trials, we
found that tetrabutylammonium iodide in the presence
of BF3-etherate8 cleaved 15 to furnish the iodotetra-
acetate 16 (Scheme 3).9 Base mediated dehydroiodina-
tion in 16 led to 17, an annulated conduritol derivative
(cf. conduritol 2). Dihydroxylation of 17 proceeded
smoothly from the face opposite to the allylic acetate
group to furnish the tetrahydroxy-tetraacetate 18 in a
stereoselective manner. Finally, the hydrolysis of the
acetate groups in 18 delivered the octahydroxydecalin,
a bicyclic inositol derivative 19 having the neo-inositol
configuration (Scheme 3). The energy minimized struc-
ture of 19 clearly showed that the inositol moiety exists
in a (4a/2e) conformation with four axial and two
equatorial hydroxyl groups. In contrast neo-inositol is
known to have a 4e/2a conformation.10 Thus, the annu-
lation tactic can be employed in the case of inositols to
access ‘un-natural’ conformations while retaining the
‘natural’ configuration as shown recently by us in
related examples.4
In another sequence, diol-diacetate 12 was converted to
the tetra-acetate 20 and subjected to a two-step allylic
bromination–dehydrobromination sequence to furnish
the bicyclic 1,3-cyclohexadiene derivative 21.11 Exhaus-
tive OsO4-mediated dihydroxylation of 21 led to the
tetrol-tetraacetate 22, and the stereochemical outcome
modulate the diastereoselectivity of the epoxidation in a
profound way. Thus, simple acetylation of the diol to
the diacetate and epoxidation reversed the selectivity
(10:1) in favor of the anti-epoxide 11 (Scheme 2), while
acetonide protection directed the epoxidation exclu-
sively from the anti-face.5,6 Interestingly, the bulky
TBDMS group exhibited only moderate selectivity in
favor of anti-addition (Scheme 2). While these studies
were in progress, O’Brien et al.7 published their detailed
studies on the epoxidation of simple cis-4,5-dihydroxy
cyclohexenes and explained the observed diastereoselec-
tivities in terms of steric effects and/or directed hydro-
gen bonding interactions. The diastereoselection
encountered during the epoxidation of 9 and its deriva-
tives closely parallel the O’Brien findings and our obser-
vations can be rationalized in an analogous manner.7
It turns out that both syn-10 and anti-11 were service-
able for our projected sequence. Thus, the mixture of
10 and 11 was converted to their diacetates and expo-
sure to mild acid led to a single trans-diol-cis-diacetate
12.6 Bromination furnished dibromide 13, which on
Scheme 3. Reagents and conditions : (a) 10% AcOH, 1 h, 85%; (b) C5H5N+HBr3−, CH2Cl2, 3 h, 77%; (c) KOtBu, tBuOH:dioxane
(1:2), rt (1 h) to 60°C (3 h), 45%; (d) i. OsO4 (1 mol%), NMMO, acetone:water (4:1), 2 h; ii. Ac2O, DMAP, CH2Cl2, 30 min, 75%
(two steps); (e) Bu4N
+I−, BF3·O(C2H5)2, CHCl3, reflux, 4 h, 73%; (f) KO
tBu, tBuOH:dioxane (1:2), 60°C, 2 h, 63%; (g) OsO4 (1
mol%), NMMO, acetone:water (4:1), 3–4 h, 60%; (h) K2CO3, CH3OH, rt, 1 h, 67%.
Scheme 4. Reagents and conditions : (a) Ac2O, BF3·O(C2H5)2, 3 h, 88%; (b) i. NBS, AIBN, CCl4, reflux, 1 h, ii. DBU, DMSO, 3
h, 56% (two steps); (c) OsO4, NMMO, acetone:water (4:1), 2 d, 52%; (d) K2CO3, CH3OH, 1 h, 95%.
was predictable in view of our experience with related
compounds.4 Acetate hydrolysis in 22 led to the annu-
lated chiro-inositol derivative 23 (Scheme 4). Once
again the energy minimized structure of 23 revealed a
4a/2e conformation, whereas the crystal structure of the
parent chiro-inositol showed it to be in a 4e/2a
conformation.12
In short, we have accomplished the synthesis of novel
cyclohexa-annulated neo- and chiro-inositols, bearing
two additional hydroxyl groups, from naphthalene fol-
lowing short, stereoselective protocols. These new inosi-
tols are locked in conformations not present in natural
inositols and pave the way for the evaluation of their
physico-chemical and biological profiles.
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